Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs

References

• LambertLCFauciASInfluenza vaccines for the futureN Engl J Med2010363212036204421083388
   PubMed Web of Science ®Google Scholar
• WHO (homepage on the internet)Influenza (Seasonal) - Fact SheetWorld Health Organization2018 Available from: http://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)Accessed October 2, 2018
   Google Scholar
• DykhuisHCPainterTFangmanTDHAssessing production parameters and economic impact of swine influenza, PRRS and Mycoplasma hyopneimoniae on finishing pigs in a large production systemPaper presented at: Proceedings of AASV Annual MeetingMarch 10–13Denver, Colorado2012
   Google Scholar
• ItoTCouceiroJNKelmSMolecular basis for the generation in pigs of influenza A viruses with pandemic potentialJ Virol1998729736773739696833
   PubMed Web of Science ®Google Scholar
• DawoodFSIulianoADReedCEstimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling studyLancet Infect Dis201212968769522738893
   PubMed Web of Science ®Google Scholar
• SchickerRSRossowJEckelSOutbreak of Influenza A(H3N2) Variant Virus Infections Among Persons Attending Agricultural Fairs Housing Infected Swine – Michigan and Ohio, July-August 2016MMWR Morb Mortal Wkly Rep201665421157116027787493
   PubMed Web of Science ®Google Scholar
• ZhangHWangLCompansRWWangBZUniversal influenza vaccines, a dream to be realized soonViruses2014651974199124784572
   PubMed Web of Science ®Google Scholar
• NoahDLNoahJWAdapting global influenza management strategies to address emerging virusesAm J Physiol Lung Cell Mol Physiol20133052L108L11723709619
   PubMed Web of Science ®Google Scholar
• ButlerDMutations explain poor showing of 2012 flu vaccine2014 Available from: http://www.nature.com/news/mutations-explain-poor-showing-of-2012-flu-vaccine-1.14940Accessed September 20, 2018
   Google Scholar
• VincentALPerezDRRajaoDInfluenza A virus vaccines for swineVet Microbiol2017206354427923501
   PubMed Web of Science ®Google Scholar
• GaugerPCVincentALLovingCLEnhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virusVaccine201129152712271921310191
   PubMed Web of Science ®Google Scholar
• VincentALLagerKMJankeBHGramerMRRichtJAFailure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccineVet Microbiol2008126431032317719188
   PubMed Web of Science ®Google Scholar
• RajaoDSSandbulteMRGaugerPCHeterologous challenge in the presence of maternally-derived antibodies results in vaccine- associated enhanced respiratory disease in weaned pigletsVirology2016491798826874588
   PubMed Web of Science ®Google Scholar
• FiersWde FiletteMBirkettANeirynckSMin JouWA “universal” human influenza A vaccineVirus Res20041031–217317615163506
   PubMed Web of Science ®Google Scholar
• LeeYTKimKHKoEJNew vaccines against influenza virusClin Exp Vaccine Res201431122824427759
   PubMedGoogle Scholar
• KrammerFPalesePAdvances in the development of influenza virus vaccinesNat Rev Drug Discov201514316718225722244
   PubMed Web of Science ®Google Scholar
• PurcellAWMccluskeyJRossjohnJMore than one reason to rethink the use of peptides in vaccine designNat Rev Drug Discov20076540441417473845
   PubMed Web of Science ®Google Scholar
• DanhierFAnsorenaESilvaJMCocoRLe BretonAPréatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
   PubMed Web of Science ®Google Scholar
• LüJMWangXMarin-MullerCCurrent advances in research and clinical applications of PLGA-based nanotechnologyExpert Rev Mol Diagn20099432534119435455
   PubMed Web of Science ®Google Scholar
• MishraNGoyalAKTiwariSRecent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriersExpert Opin Ther Pat201020566167920345332
   PubMed Web of Science ®Google Scholar
• UsonisVBakasénasVValentelisRKatilieneGVidzenieneDHerzogCAntibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal)Vaccine200321314588459214575771
   PubMed Web of Science ®Google Scholar
• WoodrowKABennettKMLoDDDdLMucosal vaccine design and deliveryAnnu Rev Biomed Eng201214174622524387
   PubMed Web of Science ®Google Scholar
• Torrieri-DramardLLambrechtBFerreiraHLvan den BergTKlatzmannDBellierBIntranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza virusesMol Ther201119360261120959813
   PubMed Web of Science ®Google Scholar
• HiremathJKangKIXiaMEntrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in PigsPLoS One2016114e015192227093541
   PubMed Web of Science ®Google Scholar
• ChengXGZhongGMMcdonoughJMacnaughtonMIn vivo evaluation of MSU crystals as an adjuvantVaccine Development Center of San Antonio Conference. 20142014 Available from: http://savaccine.org/conference/2016conference/AccessedOctober 8, 2018
   Google Scholar
• YassineHMKhatriMZhangYJCharacterization of triple reassortant H1N1 influenza A viruses from swine in OhioVet Microbiol20091391–213213919477087
   PubMed Web of Science ®Google Scholar
• AliAKhatriMWangLSaifYMLeeCWIdentification of swine H1N2/pandemic H1N1 reassortant influenza virus in pigs, United StatesVet Microbiol20121581–2606822397932
   PubMed Web of Science ®Google Scholar
• YassineHMAl-NatourMQLeeCWSaifYMInterspecies and intraspecies transmission of triple reassortant H3N2 influenza A virusesVirol J2007412918045494
   PubMed Web of Science ®Google Scholar
• KhatriMDwivediVKrakowkaSSwine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virusJ Virol20108421112101121820719941
   PubMed Web of Science ®Google Scholar
• de FiletteMFiersWMartensWImproved design and intranasal delivery of an M2e-based human influenza A vaccineVaccine20062444–466597660116814430
   PubMed Web of Science ®Google Scholar
• Vergara-AlertJArgilaguetJMBusquetsNConserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig modelPLoS One201277e4052422815759
   PubMed Web of Science ®Google Scholar
• ZhangNQiJFengSCrystal structure of swine major histocompatibility complex class I SLA-1 0401 and identification of 2009 pandemic swine-origin influenza A H1N1 virus cytotoxic T lymphocyte epitope peptidesJ Virol20118522117091172421900158
   PubMed Web of Science ®Google Scholar
• ChengXTsaoCMSaulJSylviaVCornetDChristyRComparison of Two Nanoparticle Formulations for Localized Delivery of Platelet-Derived Growth Factor (PDGF) from Aligned Collagen FibersPharmaceutical Nanotechnology201312105114
   Google Scholar
• FryDWWhiteJCGoldmanIDRapid separation of low molecular weight solutes from liposomes without dilutionAnal Biochem1978902809815727510
   PubMed Web of Science ®Google Scholar
• ChengXHagginsDGYorkRHYeniYNAkkusOAnalysis of crystals leading to joint arthropathies by Raman spectroscopy: comparison with compensated polarized imagingAppl Spectrosc200963438138619366502
   PubMed Web of Science ®Google Scholar
• DhakalSHiremathJBondraKBiodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigsJ Control Release201724719420528057521
   PubMed Web of Science ®Google Scholar
• DhakalSGoodmanJBondraKPolyanhydride nanovaccine against swine influenza virus in pigsVaccine20173581124113128117173
   PubMed Web of Science ®Google Scholar
• DwivediVManickamCPattersonRCross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvantVaccine201129234058406621419162
   PubMed Web of Science ®Google Scholar
• DwivediVManickamCDhakalSAdjuvant effects of invariant NKT cell ligand potentiates the innate and adaptive immunity to an inactivated H1N1 swine influenza virus vaccine in pigsVet Microbiol201618615716327016770
   PubMed Web of Science ®Google Scholar
• LudewigBBarchiesiFPericinMZinkernagelRMHengartnerHSchwendenerRAIn vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunityVaccine2000191233210924783
   PubMed Web of Science ®Google Scholar
• SederRAPaulWEAcquisition of lymphokine-producing phenotype by CD4+ T cellsAnnu Rev Immunol1994126356737912089
   PubMed Web of Science ®Google Scholar
• RoussetFGarciaEDefranceTInterleukin 10 is a potent growth and differentiation factor for activated human B lymphocytesProc Natl Acad Sci U S A1992895189018931371884
   PubMed Web of Science ®Google Scholar
• de BruinTGvan RooijEMde VisserYEBianchiATCytolytic function for pseudorabies virus-stimulated porcine CD4+ CD8dull+ lymphocytesViral Immunol200013451152011192298
   PubMed Web of Science ®Google Scholar
• BinjawadagiBDwivediVManickamCOuyangKTorrellesJBRenukaradhyaGJAn innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccinationInt J Nanomedicine201491519153524711701
   PubMed Web of Science ®Google Scholar
• TaoWHurstBLShakyaAKConsensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A virusesAntiviral Res2017141627228161578
   PubMed Web of Science ®Google Scholar
• KanekiyoMWeiCJYassineHMSelf-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodiesNature2013499745610210623698367
   PubMed Web of Science ®Google Scholar
• SmithGLiuYFlyerDNovel hemagglutinin nanoparticle influenza vaccine with Matrix-MTM adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypesVaccine201735405366537228844407
   PubMed Web of Science ®Google Scholar
• DengLMohanTChangTZDouble-layered protein nanoparticles induce broad protection against divergent influenza A virusesNat Commun20189135929367723
   PubMedGoogle Scholar
• SchwendenerRALiposomes as vaccine delivery systems: a review of the recent advancesTher Adv Vaccines20142615918225364509
   PubMedGoogle Scholar
• GregoriadisGMcCormackBObrenovicMPerrieYSaffieRLiposomes As Immunological Adjuvants and Vaccine CarriersVaccine Adjuvants: Preparation Methods and Research ProtocolsTotowa, NJSpringerO’HaganDT New York2000137150
   Google Scholar
• GregoriadisGImmunological adjuvants: a role for liposomesImmunol Today199011389972186746
   PubMedGoogle Scholar
• BernasconiVNorlingKBallyMHöökFLyckeNYMucosal Vaccine Development Based on Liposome TechnologyJ Immunol Res20162016548208728127567
   PubMed Web of Science ®Google Scholar
• HardingCVCollinsDSSlotJWGeuzeHJUnanueERLiposome- encapsulated antigens are processed in lysosomes, recycled, and presented to T cellsCell19916423934011899049
   PubMed Web of Science ®Google Scholar
• Tandrup SchmidtSFogedCKorsholmKSRadesTChristensenDLiposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and ImmunostimulatorsPharmaceutics2016817
   PubMed Web of Science ®Google Scholar
• ThomasCRawatAHope-WeeksLAhsanFAerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccineMol Pharm20118240541521189035
   PubMed Web of Science ®Google Scholar
• WangDChristopherMENagataLPIntranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responsesJ Clin Virol200431Suppl 199106
   PubMedGoogle Scholar
• BabaiISamiraSBarenholzYZakay-RonesZKedarEA novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in miceVaccine1999179–101223123810195636
   PubMed Web of Science ®Google Scholar
• YuLZhouYJiangYConstruction and identification of a recombinant live attenuated PRRSV expressing porcine GM-CSFZhongguo Yufang Shouyi Xuebao/Chinese Journal of Preventive Veterinary Medicine2014364260264
   Google Scholar
• FritzRSHaydenFGCalfeeDPNasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatmentJ Infect Dis1999180358659310438343
   PubMed Web of Science ®Google Scholar
• BarbéFAtanasovaKvan ReethKCytokines and acute phase proteins associated with acute swine influenza infection in pigsVet J20111871485320097110
   PubMed Web of Science ®Google Scholar
• JoSKKimHSChoSWSeoSHPathogenesis and inflammatory responses of swine H1N2 influenza viruses in pigsVirus Res20071291647017570553
   PubMed Web of Science ®Google Scholar
• KimBAhnKKHaYAssociation of tumor necrosis factor- alpha with fever and pulmonary lesion score in pigs experimentally infected with swine influenza virus subtype H1N2J Vet Med Sci200971561161619498287
   PubMed Web of Science ®Google Scholar
• YassineHMLeeCWGourapuraRSaifYMInterspecies and intraspecies transmission of influenza A viruses: viral, host and environmental factorsAnim Health Res Rev2010111537220591213
   PubMedGoogle Scholar
• TrebbienRLarsenLEViuffBMDistribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigsVirol J2011843421902821
   PubMed Web of Science ®Google Scholar
• BlishCAMcclellandRSRichardsonBAGenital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic InflammationJ Acquir Immune Defic Syndr201261443644022878424
   PubMed Web of Science ®Google Scholar
• IbrahimZBuschJAwwadMWagnerRWellsKCooperDKSelected physiologic compatibilities and incompatibilities between human and porcine organ systemsXenotransplantation200613648849917059572
   PubMed Web of Science ®Google Scholar
• RogersCSAbrahamWMBrogdenKAThe porcine lung as a potential model for cystic fibrosisAm J Physiol Lung Cell Mol Physiol20082952L240L26318487356
   PubMed Web of Science ®Google Scholar
• GocoRVKressMBBrantiganOCComparison of mucus glands in the tracheobronchial tree of man and animalsAnn N Y Acad Sci196310655557113963227
   PubMed Web of Science ®Google Scholar
• PabstRBinnsRMThe immune system of the respiratory tract in pigsVet Immunol Immunopathol1994431–31511567856047
   PubMed Web of Science ®Google Scholar
• HeinenPPRijsewijkFAde Boer-LuijtzeEABianchiATVaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virusJ Gen Virol200283Pt 81851185912124449
   PubMed Web of Science ®Google Scholar
• KitikoonPVincentALJankeBHSwine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolatesVaccine200928252353119837089
   PubMed Web of Science ®Google Scholar
• MatsuiMKohyamaSSudaTA CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic miceBiochem Biophys Res Commun201039131494149920060099
   PubMed Web of Science ®Google Scholar
• IchihashiTYoshidaRSugimotoCTakadaAKajinoKCross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity modelPLoS One201169e2462621949735
   PubMed Web of Science ®Google Scholar
• MeierWAHusmannRJSchnitzleinWMOsorioFALunneyJKZuckermannFACytokines and synthetic double-stranded RNA augment the T helper 1 immune response of swine to porcine reproductive and respiratory syndrome virusVet Immunol Immunopathol2004102329931415507313
   PubMed Web of Science ®Google Scholar
• NinomiyaAOgasawaraKKajinoKTakadaAKidaHIntranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in miceVaccine20022025–263123312912163263
   PubMed Web of Science ®Google Scholar
• BragaTTForniMFCorrea-CostaMSoluble Uric Acid Activates the NLRP3 InflammasomeSci Rep201773988428084303
   PubMed Web of Science ®Google Scholar
• NgGChauEMShiYRecent developments in immune activation by uric acid crystalsArch Immunol Ther Exp2010584273277
   PubMed Web of Science ®Google Scholar
• SakamakiIInaiKTsutaniHSafety of intradermal injection of monosodium urate crystals as a vaccine carrier in volunteersNucleosides Nucleotides Nucleic Acids201130121077108422132960
   PubMed Web of Science ®Google Scholar
• ShiYEvansJERockKLMolecular identification of a danger signal that alerts the immune system to dying cellsNature2003425695751652114520412
   PubMed Web of Science ®Google Scholar
• TausFSantucciMBGrecoEMonosodium Urate Crystals Promote Innate Anti-Mycobacterial Immunity and Improve BCG Efficacy as a Vaccine against TuberculosisPLoS One2015105e012727926023779
   PubMed Web of Science ®Google Scholar
• GeiserMKreylingWGDeposition and biokinetics of inhaled nanoparticlesPart Fibre Toxicol20107220205860
   PubMed Web of Science ®Google Scholar
• BrenzaTMPetersenLKZhangYPulmonary biodistribution and cellular uptake of intranasally administered monodisperse particlesPharm Res20153241368138225297714
   PubMed Web of Science ®Google Scholar
• KumarSAnselmoACBanerjeeAZakrewskyMMitragotriSShape and size-dependent immune response to antigen-carrying nanoparticlesJ Control Release2015220Pt A14114826437263
   PubMed Web of Science ®Google Scholar